What we achieved in 2025, together
Date
Research news
Date
The TOP HAT trial was halted in April. We’re delighted to announce that it is restarting.
Date
Parkinson’s UK has granted funding to projects aiming to advance our understanding of the causes and symptoms of Parkinson’s, as well as exploring new treatments.
Date
The results indicate that people in the study who received exenatide did not benefit compared to those who received placebo - suggesting that the drug does not slow down the progression of Parkinson’s.
Date
Following years of relentless campaigning by our community and charity, NHS England has committed to ensuring that time critical medication is delivered on time in hospitals as part of an exciting 3-year Medicines Safety Improvement Programme.
Date
Parkinson’s UK led consortium is using big data to accelerate new treatment options, aiming to unlock a cure for Parkinson’s.
Date
Measures in the Scottish government’s programme will affect the Parkinson’s community in many ways. One important new law will enable more people with Parkinson’s to take part in vital research.
Date
Parkinson's UK welcomes the first release of Lewy body dementia diagnosis data.
Date
A small study shows that adaptive deep brain stimulation is better than the standard version at controlling movement symptoms day and night for people with Parkinson’s.
Date
We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.
Date
The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.